Toxicologic Pathology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albassam, M. A.
Right arrow Articles by McGuire, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albassam, M. A.
Right arrow Articles by McGuire, E. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Toxicologic Pathology, Vol. 27, No. 2, 156-164 (1999)
DOI: 10.1177/019262339902700202

Coronary Arteriopathy in Monkeys Following Administration of CI-1020, an Endothelin A Receptor Antagonist

Mudher A. Albassam

Parke-Davis Research Institute, Mississauga, Ontario, Canada L5K 1B4

Alan L. Metz

Parke-Davis Pharmaceutical Research Division, Ann Arbor, Michigan, USA

Norbert J. Gragtmans

Parke-Davis Research Institute, Mississauga, Ontario, Canada L5K 1B4

Lena M. King

Parke-Davis Research Institute, Mississauga, Ontario, Canada L5K 1B4

Grace E. Macallum

Parke-Davis Research Institute, Mississauga, Ontario, Canada L5K 1B4

Hussein Hallak

Parke-Davis Pharmaceutical Research Division, Ann Arbor, Michigan, USA

Edward J. McGuire

Parke-Davis Research Institute, Mississauga, Ontario, Canada L5K 1B4

A selective non-peptide endothelin A (ETA) receptor antagonist, CI-1020, was administered to cynomolgus monkeys intravenously (iv) for 2 or 4 wk and orally for 4 wk. Groups consisting of 3 animals of each sex received CI-1020 at 1, 5, and 10 mg/kg/hr (iv) or orally at 250, 500, and 750 mg/kg body weight for 4 wk. Control animals received the vehicle only. In a separate experiment, 1 male was infused with 10 mg/kg/hr for 2 wk, and Monastral blue dye was administered iv to facilitate localization of lesions to the vascular walls. One female was administered saline and the dye and served as a control. One female at 1 mg/kg/hr was found dead at week 2, and 1 female at 5 mg/kg/hr was euthanatized during week 4 as a result of severe thigh swelling at the catheter site. Macroscopically, extramural coronary arteries appeared thickened and nodular in the 4-wk iv study in the female found dead at 1 mg/kg/hr, in 1 male and 1 female at 5 mg/kg/hr, and in 2 females at 10 mg/kg/hr. Histologically, Monastral blue pigment trapped in the walls of coronary arteries with arteriopathy was observed in the male treated with CI-1020 at 10 mg/kg/hr for 2 wk. Extramural coronary arteriopathy occurred at all doses in the 4-wk iv study, with higher incidence occurring in females than in males (7 of 9 treated females compared with 3 of 9 treated males). In the oral study, 1 female at 500 mg/kg/day and 1 male and 2 females at 750 mg/kg/day had coronary arteriopathy. Histological changes after 2 wk of treatment were characterized by intimal thickening, fragmentation of the internal elastic lamina, necrosis and edema of the media, and mixed inflammatory-cell infiltrates in the intima, media, and adventitia. After 4 wk of iv administration, arteriopathy was characterized by segmental disruption of the elastic lamina and intimal and medial fibrosis with complete replacement of smooth muscle with fibrous tissue. The adventitia was thickened as a result of fibrosis and mixed or mononuclear inflammatory-cell infiltrates. CI-1020 concentrations were higher in males (1.57 to 29 µg/ml) than in females (0.974 to 24.4 µg/ml) in the iv study. Transient systemic exposure with high maximum plasma concentration (Cmax) (120-352 µg/ml) in the oral study was insufficient to provoke arterial changes of the same magnitude as those noted with continuous iv administration. The regeneration of the media by fibrous tissue and the disruption of the elastic lamina may weaken the arterial wall and increase the susceptibility of the artery to the development of aneurysm.

Key Words: Endothelin A • arteriopathy • medial necrosis • vasculitis • arteritis • endothelin receptor blockade • PD 156707


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
N. Dagues, V. Pawlowski, C. Sobry, G. Hanton, F. Borde, S. Soler, J.-L. Freslon, and S. Chevalier
Investigation of the Molecular Mechanisms Preceding PDE4 Inhibitor-Induced Vasculopathy in Rats: Tissue Inhibitor of Metalloproteinase 1, a Potential Predictive Biomarker
Toxicol. Sci., November 1, 2007; 100(1): 238 - 247.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
C. Louden, D. Brott, A. Katein, T. Kelly, S. Gould, H. Jones, G. Betton, J.-P. Valetin, and R. J. Richardson
Biomarkers and Mechanisms of Drug-Induced Vascular Injury in Non-Rodents
Toxicol Pathol, January 1, 2006; 34(1): 19 - 26.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
H. B. Jones, A. Macpherson, G. R. Betton, A. S. Davis, R. Siddall, and P. Greaves
Endothelin Antagonist-Induced Coronary and Systemic Arteritis in the Beagle Dog
Toxicol Pathol, April 1, 2003; 31(3): 263 - 272.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
M. A. Albassam, A. L. Metz, R. E. Potoczak, K. P. Gallagher, S. Haleen, H. Hallak, and E. J. Mcguire
Studies on Coronary Arteriopathy in Dogs Following Administration of CI-1020, an Endothelin A Receptor Antagonist
Toxicol Pathol, April 1, 2001; 29(3): 277 - 284.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
C. S. Louden, P. Nambi, M. A. Pullen, R. A. Thomas, L. A. Tierney, H. A. Solleveld, and L. W. Schwartz
Endothelin Receptor Subtype Distribution Predisposes Coronary Arteries to Damage
Am. J. Pathol., July 1, 2000; 157(1): 123 - 134.
[Abstract] [Full Text] [PDF]